Unilever looks set to beat out Nestle in the bidding war for GlaxoSmithKline ’s Indian nutrition business . The acquisition would bring less than $ 4bn to Unilever but would strengthen the company ’s position in Indian markets , which are currently showing faster growth than Western markets . Horlicks , one of Glaxo India 's leading products , dominates India ’s nutritional drinks market , which will see a slowdown in growth . The decision to consider a sale of the business follows GSK's $13 billion acquisition of Novartis's stake in the two groups' consumer health joint venture and a change of strategic priorities under GSK CEO Emma Walmsley. Horlicks ’ growth has slowed from 15 % to 4 % between 2013 and 2017 .
Unilever looks set to beat out Nestle in the bidding war for GlaxoSmithKline ’s Indian nutrition business . The acquisition would bring less than $ 4bn to Unilever but would strengthen the company ’s position in Indian markets , which are currently showing faster growth than Western markets . Horlicks , one of Glaxo India 's leading products , dominates India ’s nutritional drinks market , which will see a slowdown in growth . Horlicks ’ growth has slowed from 15 % to 4 % between 2013 and 2017 .